ADMA logo

ADMA Biologics, Inc. (ADMA)

Profile

Full Name

ADMA Biologics, Inc.

Ticker

NASDAQ: ADMA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 17, 2013

Indexes

Not included

Website

https://www.admabiologics.com

Employees

685

Key Details

Price

$17.26(-0.69%)

Market cap

$4.12B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$426.45M(+65.15% YoY)

Annual EPS

$0.85(+753.85% YoY)

PE ratio

20.07

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $17.26
    ADMA price is $17.26

    30-Day Relative Volume

    0.60
    ADMA 30-day relative volume is 0.60

    Price Performance

    Price Most recent change

    -0.69%
    ADMA price was down -0.69% on Aug 29, 2025

    Price YTD change

    +0.64%
    ADMA price is up +0.64% since January 1st

    Price 1-year change

    +0.23%
    ADMA price is up +0.23% year-on-year

    Price 3-year change

    +539.26%
    ADMA price is up +539.26% over the past 3 years

    Price Range

    Price All-time high

    $25.67
    ADMA price is currently -32.76% below its historical high of $25.67

    Price 3-year low

    $2.24
    ADMA price is currently +670.54% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $4.12B
    ADMA market capitalization is $4.12 billion

    Market cap 3-year change

    +676.88%
    ADMA market capitalization is up +676.88% over the past 3 years

    Market cap All-time high

    $5.85B
    ADMA market capitalization is currently -29.56% below its historical high of $5.85 billion

    Market cap sector rank

    87.56%
    ADMA market capitalization is higher than 87.56% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.38%
    ADMA shares outstanding is up +2.38% year-on-year

    Shares Outstanding 3-Year Change

    +21.53%
    ADMA shares outstanding is up +21.53% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.19
    ADMA beta is 1.19

    200-day SMA

    $18.74
    ADMA price is currently -7.89% below its 200-day simple moving average

    50-day SMA

    $17.75
    ADMA price is currently -2.78% below its 50-day simple moving average

    RSI

    46.88
    ADMA 14-day relative strength index is 46.88

    Volume

    0.60
    ADMA 30-day relative volume is 0.60

    ATR

    $0.69
    ADMA average true range is $0.69

    10-day Historical Volatility

    39.44%
    ADMA 10-day historical volatility is 39.44%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $426.45M
    ADMA annual revenue is $426.45 million

    Revenue Analysts estimate

    $506.30M
    ADMA annual revenue is currently -15.77% lower than the consensus analysts' forecast

    Revenue 1-year change

    +65.15%
    ADMA annual revenue is up +65.15% year-on-year

    Revenue Sector rank

    80.25%
    ADMA annual revenue is higher than 80.25% of companies in Healthcare sector

    EPS

    EPS

    $0.85
    ADMA annual earnings per share is $0.85

    EPS Analysts estimate

    $0.56
    ADMA annual earnings per share is currently +50.44% higher than the consensus analysts' forecast

    EPS 1-year change

    +753.85%
    ADMA annual earnings per share is up +753.85% year-on-year

    EPS Sector rank

    88.7%
    ADMA annual earnings per share is higher than 88.7% of companies in Healthcare sector

    Profit

    Gross profit

    $219.16M
    ADMA annual gross profit is $219.16 million

    Gross margin

    51.39%
    ADMA annual gross profit margin is 51.39%

    Operating profit

    $138.98M
    ADMA annual operating income is $138.98 million

    Operating margin

    32.59%
    ADMA annual operating profit margin is 32.59%

    Net income

    $197.67M
    ADMA annual net profit is $197.67 million

    Net margin

    46.35%
    ADMA annual net profit margin is 46.35%

    Expenses

    Total expenses

    $228.78M
    ADMA annual total expenses is $228.78 million

    Operating expenses

    $80.18M
    ADMA annual total operating expenses is $80.18 million

    Cost of goods sold

    $207.29M
    ADMA annual cost of goods sold is $207.29 million

    Selling, general & administrative expenses

    $0.00
    ADMA annual SGA is $0.00

    Depreciation and amortization

    $8.04M
    ADMA annual depreciation & amortization is $8.04 million

    Interest expense

    $0.00
    ADMA annual interest expense is $0.00

    Income tax

    -$71.96M
    ADMA annual income tax is -$71.96 million

    EBIT & EBITDA

    EBIT

    $138.98M
    ADMA annual earnings before interest & taxes is $138.98 million

    EBITDA

    $147.03M
    ADMA annual EBITDA is $147.03 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $498.38M
    ADMA annual total assets is $498.38 million

    Non current assets

    $157.27M
    ADMA annual long term assets is $157.27 million

    Current assets

    $331.41M
    ADMA annual total current assets is $331.41 million

    Cash and cash equivalents

    $103.15M
    ADMA annual cash & cash equivalents is $103.15 million

    Accounts receivable

    $50.00M
    ADMA annual accounts receivable is $50.00 million

    Inventory

    $170.24M
    ADMA annual inventory is $170.24 million

    Liabilities

    Total liabilities

    $149.36M
    ADMA annual total liabilities is $149.36 million

    Long term liabilities

    $12.92M
    ADMA annual total long term liabilities is $12.92 million

    Current liabilities

    $55.54M
    ADMA annual total current liabilities is $55.54 million

    Accounts payable

    $20.22M
    ADMA annual accounts payable is $20.22 million

    Debt

    Total debt

    $82.12M
    ADMA annual total debt is $82.12 million

    Total debt 1-year change

    -41.93%
    ADMA annual total debt is down -41.93% year-on-year

    Long term debt

    $80.90M
    ADMA annual long term debt is $80.90 million

    Short term debt

    $1.22M
    ADMA annual short term debt is $1.22 million

    Equity & Capital

    Shareholders equity

    $349.02M
    ADMA annual stockholders equity is $349.02 million

    Book value

    $349.02M
    ADMA annual book value is $349.02 million

    Retained earnings

    -$308.58M
    ADMA annual retained earnings is -$308.58 million

    Working capital

    $275.87M
    ADMA annual working capital is $275.87 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $118.67M
    ADMA annual cash flow from operations is $118.67 million

    Cash from operations 1-year change

    +1248.55%
    ADMA annual cash flow from operations is up +1248.55% year-on-year

    Cash from investing

    -$8.57M
    ADMA annual cash flow from investing activities is -$8.57 million

    Cash from investing 1-year change

    -72.15%
    ADMA annual cash flow from investing activities is down -72.15% year-on-year

    Cash from financing

    -$58.30M
    ADMA annual cash flow from financing activities is -$58.30 million

    Cash from financing 1-year change

    -49.53%
    ADMA annual cash flow from financing activities is down -49.53% year-on-year

    CAPEX

    CAPEX

    $8.57M
    ADMA annual capital expenditures is $8.57 million

    CAPEX 1-year change

    +72.15%
    ADMA annual capital expenditures is up +72.15% year-on-year

    Free Cash Flow

    Free cash flow

    $110.10M
    ADMA annual free cash flow is $110.10 million

    Free cash flow 1-year change

    +2782.88%
    ADMA annual free cash flow is up +2782.88% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    51.39%
    ADMA annual gross profit margin is 51.39%

    Operating margin

    32.59%
    ADMA annual operating profit margin is 32.59%

    Net margin

    46.35%
    ADMA annual net profit margin is 46.35%

    ROA & ROE

    ROA

    47.77%
    ADMA annual return on assets is 47.77%

    ROE

    81.65%
    ADMA annual return on equity is 81.65%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    20.07
    ADMA price to earnings ratio is 20.07

    PE ratio Sector rank

    41.86%
    ADMA price to earnings ratio is higher than 41.86% of companies in Healthcare sector

    PB Ratio

    PB ratio

    10.34
    ADMA price to book ratio is 10.34

    PB ratio Sector rank

    89.53%
    ADMA price to book ratio is higher than 89.53% of companies in Healthcare sector

    PS Ratio

    PS ratio

    8.69
    ADMA price to sales ratio is 8.69

    PS ratio Sector rank

    71.17%
    ADMA price to sales ratio is higher than 71.17% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $4.11B
    ADMA enterprise value is $4.11 billion

    Enterprise value Sector rank

    86.91%
    ADMA enterprise value is higher than 86.91% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    25.21
    ADMA EV/EBITDA is 25.21

    EV/EBITDA Sector rank

    92.93%
    ADMA EV/EBITDA is higher than 92.93% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.97
    ADMA annual current ratio is 5.97

    Quick ratio

    2.90
    ADMA annual quick ratio is 2.90

    Leverage

    Debt to equity

    0.24
    ADMA annual debt to equity ratio is 0.24

    Interest coverage ratio

    -
    ADMA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    6
    ADMA piotroski f-score is 6

    Altman Z-Score

    18.12
    ADMA altman z-score is 18.12

    Analyst ratings

    Recent major analysts updates

    May 8, 25 Raymond James
    Strong Buy
    Mar 4, 25 Cantor Fitzgerald
    Overweight
    Nov 8, 24 Raymond James
    Strong Buy
    Nov 8, 24 HC Wainwright & Co.
    Buy
    Oct 14, 24 HC Wainwright & Co.
    Buy
    Sep 20, 24 Cantor Fitzgerald
    Overweight
    Aug 12, 24 HC Wainwright & Co.
    Buy
    Aug 9, 24 Cantor Fitzgerald
    Overweight
    Jul 9, 24 Cantor Fitzgerald
    Overweight
    Jun 20, 24 Mizuho
    Buy

    Institutional Ownership

    Screeners with ADMA included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    • What is the ticker symbol for ADMA Biologics, Inc.?
    • Does ADMA Biologics, Inc. pay dividends?
    • What sector is ADMA Biologics, Inc. in?
    • What industry is ADMA Biologics, Inc. in?
    • What country is ADMA Biologics, Inc. based in?
    • When did ADMA Biologics, Inc. go public?
    • Is ADMA Biologics, Inc. in the S&P 500?
    • Is ADMA Biologics, Inc. in the NASDAQ 100?
    • Is ADMA Biologics, Inc. in the Dow Jones?
    • When was ADMA Biologics, Inc.'s last earnings report?
    • When does ADMA Biologics, Inc. report earnings?

    What is the ticker symbol for ADMA Biologics, Inc.?

    The ticker symbol for ADMA Biologics, Inc. is NASDAQ:ADMA

    Does ADMA Biologics, Inc. pay dividends?

    No, ADMA Biologics, Inc. does not pay dividends

    What sector is ADMA Biologics, Inc. in?

    ADMA Biologics, Inc. is in the Healthcare sector

    What industry is ADMA Biologics, Inc. in?

    ADMA Biologics, Inc. is in the Biotechnology industry

    What country is ADMA Biologics, Inc. based in?

    ADMA Biologics, Inc. is headquartered in United States

    When did ADMA Biologics, Inc. go public?

    ADMA Biologics, Inc.'s initial public offering (IPO) was on October 17, 2013

    Is ADMA Biologics, Inc. in the S&P 500?

    No, ADMA Biologics, Inc. is not included in the S&P 500 index

    Is ADMA Biologics, Inc. in the NASDAQ 100?

    No, ADMA Biologics, Inc. is not included in the NASDAQ 100 index

    Is ADMA Biologics, Inc. in the Dow Jones?

    No, ADMA Biologics, Inc. is not included in the Dow Jones index

    When was ADMA Biologics, Inc.'s last earnings report?

    ADMA Biologics, Inc.'s most recent earnings report was on August 6, 2025

    When does ADMA Biologics, Inc. report earnings?

    The next expected earnings date for ADMA Biologics, Inc. is November 6, 2025
    On this page